Literature DB >> 10462371

Resting energy expenditure should be measured in patients with cirrhosis, not predicted.

A M Madden1, M Y Morgan.   

Abstract

Measurements of resting energy expenditure (REE) can be used to determine energy requirements. Prediction formulae can be used to estimate REE but have not been validated in cirrhotic patients. REE was measured, by indirect calorimetry, in 100 cirrhotic patients and 41 comparable healthy volunteers, and the results compared with estimates predicted using the Harris-Benedict, Schofield, Mifflin, Cunningham, and Owen formulae, and the disease-specific Müller formula. The mean (+/- 1 SD) measured REE in the healthy volunteers (1,590 +/- 306 kcal/24 h) was significantly greater than the mean Harris-Benedict, Mifflin, Cunningham, and Owen predictions but comparable with the mean Schofield prediction; individual predicted values varied widely from measured values (95% limits of agreement, -460 to +424 kcal). The mean measured REE in the cirrhotic patients was significantly greater than in the healthy volunteers (23.2 +/- 3. 8 cf 21.9 +/- 2.9 kcal/kg/24 h; P <.05). The mean measured REE in the cirrhotic patients (1,660 +/- 337 kcal/24 h) was significantly different from mean predicted values (Harris-Benedict, 1,532 +/- 252 kcal/24 h, P <.0001; Schofield, 1,575 +/- 254 kcal/24 h, P <.0005; Mifflin, 1,460 +/- 254 kcal/24 h, P <.0001; Cunningham, 1,713 +/- 252 kcal/24 h, P <.05; Owen, 1,521 +/- 281 kcal/24 h, P <.0001; Müller, 1,783 +/- 204 kcal/24 h, P <.0001); individual predicted values varied widely from measured values (95% limits of agreement, -632 to +573 kcal). Simple regression analysis showed that fat-free mass (FFM) was the strongest predictor of measured REE in the cirrhotic patients, accounting for 52% of the variation observed. However, a population-specific prediction equation, derived using stepwise regression analysis, which incorporated FFM, age, and Pugh's score, accounted for only 61% of the observed variation in measured REE. REE should, therefore, be measured in cirrhotic patients, not predicted.

Entities:  

Mesh:

Year:  1999        PMID: 10462371     DOI: 10.1002/hep.510300326

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Nutrition in hepatic failure and liver transplantation.

Authors:  J Aranda-Michel
Journal:  Curr Gastroenterol Rep       Date:  2001-08

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

5.  LncRNA TUG1 regulates autophagy-mediated endothelial-mesenchymal transition of liver sinusoidal endothelial cells by sponging miR-142-3p.

Authors:  Rui Zhang; Xiao-Quan Huang; Ying-Yi Jiang; Na Li; Jian Wang; Shi-Yao Chen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

6.  Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation.

Authors:  Maria Teresa Diz-Lois; Jesús Garcia-Buela; Francisco Suarez; Susana Sangiao-Alvarellos; Ovidio Vidal; Fernando Cordido
Journal:  Endocrine       Date:  2009-04-11       Impact factor: 3.633

Review 7.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

8.  Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma.

Authors:  Kazuki Yamada; Takeshi Suda; Yuko S Komoro; Tsutomu Kanefuji; Tomoyuki Kubota; Toshiko Murayama; Hideaki Nakayama; Yutaka Aoyagi
Journal:  Nutr J       Date:  2013-06-08       Impact factor: 3.271

9.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Hepatology       Date:  2021-09       Impact factor: 17.298

10.  Compound Pollen Protein Nutrient Increases Serum Albumin in Cirrhotic Rats.

Authors:  Hong Bo Shi; Ming Kong; Gong Chen; Jun Zhao; Hong Lin Shi; Yu Chen; Frank G Rowan
Journal:  Gastroenterology Res       Date:  2010-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.